SURABGENE LOMPARVOVEC
UNII GJI4EV4B3C

Substance Identification & Data

This profile provides standardized clinical and technical data for Surabgene Lomparvovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GJI4EV4B3C.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2374935-18-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
GJI4EV4B3C
CAS Registry Number
2374935-18-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SURABGENE LOMPARVOVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C206993
National Cancer Institute reference terminology for clinical and research data.
INN ID
12742
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Surabgene Lomparvovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SURABGENE LOMPARVOVEC

Common Names & Synonyms

DNA (RECOMBINANT REPLICATION-DEFECTIVE ADENO-ASSOCIATED VIRUS 8 VECTOR RGX-314 CYTOMEGALOVIRUS IMMEDIATE-EARLY ENHANCER ELEMENT PLUS CHICKEN .BETA.-ACTIN GENE PROMOTER PLUS CHICKEN .BETA.-ACTIN GENE INTRON PLUS HUMAN-MUS MUSCULUS ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR) IMMUNOGLOBULIN G1 FAB FRAGMENT .GAMMA.1-CHAIN FUSION PROTEIN WITH SYNTHETIC F2A PEPTIDE LINKER FUSION PROTEIN WITH HUMAN-MUS MUSCULUS IMMUNOGLOBULIN .KAPPA.-CHAIN CODON-OPTIMIZED GENE PLUS RABBIT .BETA.-GLOBIN POLYADENYLATION SIGNAL PLUS ADENO-ASSOCIATED VIRUS 8 INVERTED TERMINAL REPEAT FLANKS)
RECOMBINANT, NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 8 (RAAV8) VECTOR ENCODING A SOLUBLE HUMANISED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ANTIBODY FRAGMENT (FAB) UNDER CONTROL OF A HYBRID CYTOMEGALOVIRUS (CMV) IMMEDIATE-EARLY ENHANCER/CHICKEN .BETA.-ACTIN PROMOTER, ENHANCED BY A CHICKEN .BETA.-ACTIN INTRON AND TERMINATED BY A RABBIT .BETA.-GLOBIN POLYADENYLATION SIGNAL. THE HEAVY AND LIGHT CHAINS OF THE FAB ARE SEPARATED BY A SELF-CLEAVING FURIN /F2A LINKER AND THE TRANSGENE IS FLANKED BY ADENO-ASSOCIATED VIRUS 2 (AAV2) INVERTED TERMINAL REPEATS (ITRS)
SURABGENE LOMPARVOVEC [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus